Abstract | OBJECTIVE: METHODS: A total of 18 young women, seven with acute AN (A-AN), four with AN in the recovery phase (R-AN), and seven with morbid OB, were studied. All subjects underwent an infusion of SRIF (9 μg/kg i.v./h, over 60 min), with blood samples drawn before and at different time intervals after SRIF administration. Plasma PYY levels were measured at each time point. RESULTS: SRIF significantly inhibited plasma PYY concentrations in R-AN and OB, without affecting PYY titers in A-AN. In OB, the inhibitory effect of SRIF also persisted at 90 min. Withdrawal of SRIF infusion in R-AN resulted in a prompt restoration of basal plasma PYY levels, whereas termination of SRIF infusion in OB was followed by a slower increase of PYY titers toward baseline levels. After infusion, PYY Δ area under the curve (ΔAUC) in R-AN was significantly higher than those in A-AN and OB patients. A significant difference in PYY ΔAUC between A-AN and OB was present. CONCLUSIONS: These results suggest the existence of a hypo- and hyper-sensitivity of L cells to the inhibitory effect of SRIF in A-AN and OB respectively.
|
Authors | Antonello E Rigamonti, Silvano G Cella, Sara M Bonomo, Giuseppe Mancia, Guido Grassi, Mario Perotti, Fiorenza Agosti, Alessandro Sartorio, Eugenio E Müller, Angela I Pincelli |
Journal | European journal of endocrinology
(Eur J Endocrinol)
Vol. 165
Issue 3
Pg. 421-7
(Sep 2011)
ISSN: 1479-683X [Electronic] England |
PMID | 21677050
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
|
Topics |
- Adolescent
- Adult
- Anorexia Nervosa
(physiopathology)
- Body Mass Index
- Female
- Humans
- Obesity, Morbid
(physiopathology)
- Peptide YY
(blood, metabolism)
- Postprandial Period
- Somatostatin
|